The expression of IL-17A and IL-17F is heterogeneous and confined to a subset of patients which is likely the cause of discrepant reports regarding their expression in CTCL [55, 62, 70–73]. This evidence concerns the gene IL17F and primary cutaneous T-cell non-Hodgkin lymphoma.